Alibaba
BABA
Micron Technology
MU
NVIDIA
NVDA
Cisco
CSCO
Netflix
NFLX
US Stock MarketDetailed Quotes
ORKA Oruka Therapeutics
- 11.180
- -0.250-2.19%
Close Feb 14 16:00 ET
- 11.180
- 0.0000.00%
Post 20:01 ET
391.28MMarket Cap-29.42P/E (TTM)
11.905High10.830Low248.88KVolume11.170Open11.430Pre Close2.80MTurnover1.06%Turnover RatioLossP/E (Static)35.00MShares33.00052wk High1.15P/B261.68MFloat Cap10.13352wk Low--Dividend TTM23.41MShs Float40838092.445Historical High--Div YieldTTM9.41%Amplitude10.068Historical Low11.246Avg Price1Lot Size
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Oruka Therapeutics Stock Forum
Oruka Therapeutics Announces Preclinical Data for ORKA-001 at the European Academy of Dermatology and Venereology Congress
Half-life in non-human primates (NHP) of 30.3 days after subcutaneous (SQ) administration and 33.8 days after intravenous (IV) administration
Equivalent potency to risankizumab with similar binding affinity and epitope demonstrated in several preclinical assays
MENLO PARK, Calif., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc...
looking forward to see how this performs
No comment yet